Skip to main contentSkip to navigation
Sirius Investors
Third Harmonic Bio, Inc.

Third Harmonic Bio, Inc.

THRD
NASDAQHealthcare

Third Harmonic Bio, Inc. (THRD) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Third Harmonic Bio, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2024
P/E Ratio
9.44
Strong
WeakModerateStrong
P/B Ratio
1.51
Strong
WeakModerateStrong
Earnings Yield
10.59%
Strong
WeakModerateStrong

Profitability Health

2024
Return on Equity
15.95%
Strong
WeakModerateStrong
Operating Margin
-
No data
Net Profit Margin
-
No data

Growth Indicators

2024
Revenue Growth
-
No data
Net Income Growth
247.51%
Strong
WeakModerateStrong
EPS Growth
239.74%
Strong
WeakModerateStrong

Efficiency & Liquidity

2024
Current Ratio
40.87
Strong
WeakModerateStrong
Quick Ratio
40.87
Strong
WeakModerateStrong
Asset Turnover
-
No data
Inventory Turnover
-
No data

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2024
Free Cash Flow Yield
-8.04%
Weak
WeakModerateStrong
EV / Free Cash Flow
-4.28x
Strong
WeakModerateStrong
Net Debt / EBITDA
6.21x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.772
Weak
WeakModerateStrong
Return on Invested Capital
20.42%
Strong
WeakModerateStrong
Cash Conversion Cycle
0.00 days
Strong
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for THRD.

View Financial Statements